Aditxt, Inc. (ADTX) vs Jupiter Neurosciences, Inc. (JUNS)

Aditxt, Inc. and Jupiter Neurosciences, Inc. are both Biotechnology companies. Aditxt, Inc. and Jupiter Neurosciences, Inc. are of similar size ($4.4M and $4.1M). Jupiter Neurosciences, Inc. has the higher net margin (0.00% vs −372,998.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Aditxt, Inc. leads on 5 and Jupiter Neurosciences, Inc. on 5.

Valuation

Metric ADTX JUNS Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 73.26 n/m 9.21
Earnings yield 0.00% (656.97%) (33.15%)
Free cash flow yield 0.00% (446.77%) (25.50%)

Profitability

Metric ADTX JUNS Biotechnology median
Gross margin 20.28% — 65.16%
Operating margin (128,143.36%) 0.00% 0.00%
Net margin (372,998.60%) 0.00% 0.00%
Free cash flow margin (129,979.72%) 0.00% 0.00%
Return on equity 549.59% (1,888.80%) (56.36%)
Return on assets (236.38%) (239.36%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADTX JUNS Biotechnology median
Revenue growth (TTM) (74.19%) — 6.02%
EPS growth (last fiscal year) (918.27%) (212.50%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ADTX JUNS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.06 0.66 4.72
Net debt to EBITDA 0.18 0.43 0.96

Dividend

Metric ADTX JUNS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ADTX JUNS Biotechnology median
Market cap 4.39m 4.14m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack